Spero Therapeutics (SPRO) Shareholder's Equity (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.31% |
| Dec 31, 2025 | 122.77% |
| Sep 30, 2025 | -19.29% |
| Jun 30, 2025 | -2.92% |
| Mar 31, 2025 | -26.69% |
| Dec 31, 2024 | -29.59% |
| Sep 30, 2024 | -18.62% |
| Jun 30, 2024 | -16.36% |
| Mar 31, 2024 | -9.96% |
| Dec 31, 2023 | 99.04% |
| Sep 30, 2023 | -1.97% |
| Jun 30, 2023 | -15.51% |
| Mar 31, 2023 | -14.61% |
| Dec 31, 2022 | 133.76% |
| Sep 30, 2022 | -9.57% |
| Jun 30, 2022 | -42.50% |
| Mar 31, 2022 | -29.24% |
| Dec 31, 2021 | -21.10% |
| Sep 30, 2021 | 23.98% |
| Jun 30, 2021 | -24.06% |
| Mar 31, 2021 | -9.99% |
| Dec 31, 2020 | -0.56% |
| Sep 30, 2020 | 80.14% |
| Jun 30, 2020 | -10.57% |
| Mar 31, 2020 | 10.53% |
| Dec 31, 2019 | -19.84% |
| Sep 30, 2019 | -15.17% |
| Jun 30, 2019 | -3.23% |
| Mar 31, 2019 | -2.18% |
| Dec 31, 2018 | -7.72% |
| Sep 30, 2018 | 91.19% |
| Jun 30, 2018 | -12.32% |
| Mar 31, 2018 | -11.84% |
| Dec 31, 2017 | 203.82% |